Form 4: Moderna Director Noubar Afeyan Sells Shares Under 10b5-1 Trading Plan

Noubar Afeyan, a director at Moderna, sold shares of the company's common stock on July 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On July 31, 2024, Noubar Afeyan, a director of Moderna, sold shares of the company's common stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on February 27, 2023, and amended on November 7, 2023.
• A total of 15,000 shares were sold in multiple transactions at weighted average prices ranging from $118.9622 to $121.6229.
• Following the reported transactions, Afeyan directly owns 2,224,015 shares of Moderna common stock.
• Afeyan also indirectly owns shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
• He disclaims beneficial ownership of these indirectly held shares except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.

Industry Context

Sales by insiders are a common occurrence and are often pre-planned, especially when executed under a 10b5-1 trading plan. These plans allow insiders to sell shares at predetermined times and prices to avoid accusations of trading on non-public information. The market typically views these sales in the context of the overall trading plan and the insider's remaining holdings.

Comparison to Industry Standards

• Comparing Moderna to other biotechnology companies like Pfizer, BioNTech, and Johnson & Johnson, insider trading activity is a common occurrence.
• However, the scale and frequency of these transactions can vary significantly based on company performance, stock valuation, and individual financial planning.
• For example, executives at Pfizer and Johnson & Johnson also utilize 10b5-1 plans for regular stock sales, aligning with industry best practices for managing insider trading risks.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market.
• However, since the sale was pre-planned under a 10b5-1 trading plan, the impact is likely to be minimal.

Key Dates